These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6995041)

  • 1. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Clin Pharmacol Ther; 1980 Jun; 27(6):733-43. PubMed ID: 6991196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic response to captopril at rest and during exercise in hypertensive patients.
    Fagard R; Lijnen P; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1569-71. PubMed ID: 7041600
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of the sympathomimetic activity of oxprenolol on haemodynamics in the anaesthetized dog.
    Stepanek J; Brunner H
    Basic Res Cardiol; 1975; 70(5):574-83. PubMed ID: 1203050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic and non-autonomic circulatory components in essential hypertension in man.
    Korner PI; Shaw J; Uther JB; West MJ; McRitchie RJ; Richards JG
    Circulation; 1973 Jul; 48(1):107-17. PubMed ID: 4781232
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
    Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
    J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term hemodynamic effects of bunitrolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(1):77-83. PubMed ID: 94384
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease.
    Lecerof H; Malmborg RO
    Acta Med Scand; 1972 Dec; 192(6):499-506. PubMed ID: 4629694
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R
    Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac performance and beta-adrenergic blockade in arterial hypertension.
    Guazzi M; Polese A; Fiorentini C; Olivari MT; Magrini F
    Am J Med Sci; 1977; 273(1):63-9. PubMed ID: 322485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic studies in hypertensive patients treated by oral proranolol.
    Prichard BN; Shinebourne E; Fleming J; Hamer J
    Br Heart J; 1970 Mar; 32(2):236-40. PubMed ID: 5440518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of propranolol and nitroglycerin in normal subjects during submaximal exercise.
    Nordenfelt I; Persson S
    Acta Med Scand; 1969 Nov; 186(5):407-10. PubMed ID: 4985109
    [No Abstract]   [Full Text] [Related]  

  • 17. Right ventricular performance in essential hypertension after beta-blockade.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Br Heart J; 1981 Jul; 46(1):23-9. PubMed ID: 7023516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
    Hansson L; Zweifler AJ; Julius S; Hunyor SN
    Acta Med Scand; 1974; 196(1-2):27-34. PubMed ID: 4370849
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
    Schlesinger Z; Ravid M; Meshulam R
    Cardiology; 1983; 70(4):199-205. PubMed ID: 6357438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
    van Herwaarden CL; Binkhorst RA; Fennis JF; van't Laar A
    Br Heart J; 1979 Jan; 41(1):99-105. PubMed ID: 371643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.